Biopreservation Market by Product, Biospecimens, Application, End-User

List of Tables

[192 Pages Report] The Biopreservation Market size was estimated at USD 8.70 billion in 2023 and expected to reach USD 9.89 billion in 2024, at a CAGR 13.79% to reach USD 21.49 billion by 2030.

Biopreservation is the process of preserving biological materials, such as cells, tissues, and organs, by stabilizing their metabolic activity at reduced temperatures. It plays a crucial role in various fields like medicine, agriculture, and biodiversity conservation. The significance of biopreservation lies in its ability to maintain the function and integrity of biological samples for extended periods, thereby facilitating research efforts, improving clinical outcomes in regenerative medicine, and conserving genetic resources. However, establishing and maintaining specialized facilities for biopreservation can be expensive, impeding their fast adoption in small-scale end-user facilities. Moreover, the need for trained personnel to handle sensitive biological materials adds an additional layer of complexity to managing these resources. Market players are working on introducing cost-effective biopreservation methods by advancing cryopreservation, vitrification, and hypothermic storage. The development of new cryoprotective agents (CPAs) with reduced toxicity has significantly improved the efficiency of preservation processes. Ongoing advancements are aimed at overcoming inherent limitations and enhancing the efficiency of preservation methods to ensure optimal outcomes in research, clinical applications, and biodiversity conservation efforts.

KEY MARKET STATISTICS
Base Year [2023]	USD 8.70 billion
Estimated Year [2024]	USD 9.89 billion
Forecast Year [2030]	USD 21.49 billion
CAGR (%)	13.79%

Type: Increasing adoption of cryopreservation as a preferred technique of biopreservation

Cryopreservation is a biopreservation technique that involves freezing biological samples, such as cells, tissues, or even whole organisms, at extremely low temperatures. This method is commonly used in the preservation of sperm, eggs, embryos, and other cells for research. Chemical preservation relies on the use of chemicals to arrest the degradation and decay of biological samples. This method is widely applied in histology, pathology, and electron microscopy to prepare tissue samples for examination under a microscope.

Product: Introduction of new biopreservation equipment with improved features and reliability

Biopreservation media are formulated to extend the viability and stability of biological samples, such as cells, tissues, and organs. These media contain a variety of components, including cryoprotectants and antioxidants, which protect biological material from damage during freezing, thawing, or storage. Biopreservation equipment includes a range of specialized devices and instruments used in the preservation of biological samples. It includes cryogenic freezers, bioreactors, sample storage systems, and incubators. LIMS plays an important role in maintaining sample traceability and ensuring data integrity. It helps researchers and lab personnel efficiently catalog, track, and retrieve samples.

Biospecimen: Enhanced capabilities of biopreservation to protect cell and tissue matters

Biopreservation of microorganisms, including bacteria, fungi, and viruses, involved freezing or lyophilization to maintain their viability for research applications. Cells from various sources, such as human, animal, and plant tissues, can be preserved for research, transplantation, or therapeutic use. Preserving whole organs, such as hearts, kidneys, or livers, is crucial for transplantation. Organ biopreservation includes cold storage or perfusion techniques to extend their life until they can be transplanted.

Application: Potential use of biopreservation activities during clinical trials

Biobanking involves preserving biological samples for research, diagnostics, and future studies. Clinical trials maintain the integrity of biological specimens for accurate trial results, while drug discovery includes storing cell lines and tissues for screening potential drug candidates. Regenerative medicine includes preserving stem cells and tissues for transplantation and regenerative therapies. In therapeutics, biopreservation is necessary to ensure the stability of biopharmaceuticals during storage and transport.

End-User: Emerging need for biopreservation activities among gene banks worldwide

Biopreservation serves various end-users, including gene banks, which store genetic material for research. Biobanks use it to preserve medical samples for research activities. Hospitals benefit from preserving tissues and organs for transplantation, aiding patient care.

Regional Insights

In the Americas, particularly in North America, the biopreservation industry is driven by advancements in regenerative medicine, increased investments in life sciences research, and growing awareness regarding personalized medicine. The United States and Canada observe a growing market owing to its strong healthcare infrastructure and the presence of major market players. Asia's biopreservation market is rapidly expanding due to its booming pharmaceutical industry and increasing government support towards biological research activities. Nations such as China, India, South Korea, and Japan are witnessing growing demands for biopreservation solutions as they invest heavily in stem cell research & therapy development. Europe's biopreservation market is primarily driven by a strong focus on research & development in the life sciences sector and increasing funding for personalized medicine initiatives. The European Union (EU) has been investing significantly in projects such as the Innovative Medicines Initiative (IMI) aimed at accelerating the development of safer and more effective treatments. Biobanking is also widely practiced across Europe, with many countries having established national biobanks.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Biopreservation Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biopreservation Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Biopreservation Market, highlighting leading vendors and their innovative profiles. These include Audubon Bioscience, Azenta Life Sciences, Bio-Techne Corporation, BioIVT LLC, BioLife Solutions Inc., Charles River Laboratories International, Inc., Chart Industries, Inc., Eppendorf SE, Exact Sciences Corporation, Helmer Scientific Inc., LANXESS Corporation, Lifeline Scientific Inc., Merck KGaA, MVE Biological Solutions, OPS Diagnostics, LLC, Princeton CryoTech Inc., REPROCELL Inc., Sierra Molecular Corporation, So-Low Environmental Equipment Co., STEMCELL Technologies Inc., Taylor-Wharton, Thermo Fisher Scientific Inc., ThermoGenesis Holdings, Inc., Upkara, and X-Therma Inc..

Market Segmentation & Coverage

This research report categorizes the Biopreservation Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Biopreservation Media
  - Aldehydes
  - Cryoprotective Agents

Equipment
- Consumables
- Freezers
- Nitrogen Tanks
- Refrigerators

Lab Information Management Systems

Biospecimens
- Cells
- Microorganisms
- Organs

Application
- Bio-Banking
- Clinical Trials
- Drug Discovery
- Regenerative Medicine
- Therapeutics

End-User
- Biobanks
- Gene Bank
- Hospitals

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Biopreservation Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biopreservation Market?

3. What are the technology trends and regulatory frameworks in the Biopreservation Market?

4. What is the market share of the leading vendors in the Biopreservation Market?

5. Which modes and strategic moves are suitable for entering the Biopreservation Market?

Product Code: MRR-437D45957B50

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Growing trend of conserving cord blood stem cells of newborns
  - 5.1.1.2. Increasing demand for personalized medicine
  - 5.1.1.3. Rising adoption of biopreservation in the food sector
- 5.1.2. Restraints
  - 5.1.2.1. High cost of biopreservation equipment
- 5.1.3. Opportunities
  - 5.1.3.1. Growing investments in the field of regenerative medicine research
  - 5.1.3.2. Increasing demand for room temperature storage technologies
- 5.1.4. Challenges
  - 5.1.4.1. Complications associated with regulations in the food and medical industry
5.2. Market Segmentation Analysis
- 5.2.1. Type: Increasing adoption of cryopreservation as a preferred technique of biopreservation
- 5.2.2. Product: Introduction of new biopreservation equipment with improved features and reliability
- 5.2.3. Biospecimen: Enhanced capabilities of biopreservation to protect cell and tissue matters
- 5.2.4. Application: Potential use of biopreservation activities during clinical trials
- 5.2.5. End-User: Emerging need for biopreservation activities among gene banks worldwide
5.3. Market Disruption Analysis
5.4. Porter's Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Biopreservation Market, by Product

6.1. Introduction
6.2. Biopreservation Media
6.3. Equipment
6.4. Lab Information Management Systems

7. Biopreservation Market, by Biospecimens

7.1. Introduction
7.2. Cells
7.3. Microorganisms
7.4. Organs

8. Biopreservation Market, by Application

8.1. Introduction
8.2. Bio-Banking
8.3. Clinical Trials
8.4. Drug Discovery
8.5. Regenerative Medicine
8.6. Therapeutics

9. Biopreservation Market, by End-User

9.1. Introduction
9.2. Biobanks
9.3. Gene Bank
9.4. Hospitals

10. Americas Biopreservation Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Biopreservation Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Biopreservation Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
- 13.3.1. ViVa: One of Italy's Largest Research Biobanks to be Launched via Collaboration Between ISS and SIAD
- 13.3.2. BioLife Solutions Launches the IntelliRate i67C Liquid Nitrogen (LN2) Controlled-Rate Freezer
- 13.3.3. Upkara Secures $9M to Fuel Growth and Bring Game-Changing Biopreservation Technology to Market
13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

14.1. Key Company Profiles
14.2. Key Product Portfolio